Corporate news: QLT/Forsight Newco acquisition & that new punctal plug technology

This is not directly related to dry eye but this emerging technology about a punctal plug drug delivery system is kind of intriguing (as well as worrying, frankly). Stay tuned on this one.

QLT hits 52-low on eye deal - October 9, 2007

As the first clinical candidate utilizing this cutting edge platform technology, it will target glaucoma, by replacing eye drops, dry eye, allergies and postoperative care. The company expects the products to represent a $6 billion market.